Skip to content

Clinical trials

Completed Observational trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Observational Status: Completed Country / region: Netherlands Clear all

1,556 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20014
20027
20035
200421
200522
200637
200735
200844
200958
201073
201171
201296
201385
2014103
2015117
201685
2017100
201889
201990
202083
202179
2022114
202366
202446
20259
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed1,556

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Medical Center Groningen114
Maastricht University Medical Center112
Radboud University Medical Center111
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)69
Erasmus Medical Center55
UMC Utrecht44
Rijnstate Hospital36
Amsterdam UMC, location VUmc33
Leiden University Medical Center33
Maastricht Radiation Oncology33

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease45
Breast Neoplasms39
Neoplasms37
Atrial Fibrillation35
COVID-1933
Heart Failure29
Pulmonary Disease, Chronic Obstructive29
Aortic Valve Stenosis26
Cardiovascular Diseases25
Diabetes Mellitus24

Trials

Showing 1 to 25 of 1,556. Each trial links to its page on Pharma Observatory.

1,456 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.